Everand Logo

Welcome to Everand!

  • STAT

    Opinion: San Francisco’s Mission Bay life science sector: pivoting with the times

    While #MissionBay hasn't quite captured the magnitude of biotech and pharma players as has #KendallSquare in Cambridge, the growth of its life sciences industry will continue in a very Left…
    by Chris Haskell Oct 24, 2019 2 minutes
    An aerial shot of San Francisco

    Twenty years ago, San Francisco’s Mission Bay was an industrial zone filled with shipyards and railroad tracks. It was sluggish by day and deserted by night. Today, it is a vibrant health and biotech hub that continues to evolve. A note to the media: Don’t box us in.

    When my company, Bayer, relocated its California research and innovation teams to Mission Bay in 2010, the decision was

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks